Verrica Pharmaceuticals (STU:1NE) Accumulated Depreciation : €-1.12 Mil (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Verrica Pharmaceuticals Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Verrica Pharmaceuticals's quarterly accumulated depreciation increased from Dec. 2023 (€-1.08 Mil) to Mar. 2024 (€-1.20 Mil) but then stayed the same from Mar. 2024 (€-1.20 Mil) to Jun. 2024 (€-1.12 Mil).

Verrica Pharmaceuticals's annual accumulated depreciation increased from Dec. 2021 (€-0.23 Mil) to Dec. 2022 (€-0.66 Mil) and increased from Dec. 2022 (€-0.66 Mil) to Dec. 2023 (€-1.08 Mil).

Verrica Pharmaceuticals Accumulated Depreciation Historical Data

The historical data trend for Verrica Pharmaceuticals's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verrica Pharmaceuticals Accumulated Depreciation Chart

Verrica Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

Get a 7-Day Free Trial

-0.08

-0.10

-0.23

-0.66

-1.08

Verrica Pharmaceuticals Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Accumulated Depreciation	Get a 7-Day Free Trial															-0.89	-0.98	-1.08	-1.20	-1.12

Verrica Pharmaceuticals Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Verrica Pharmaceuticals Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Verrica Pharmaceuticals's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Verrica Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verrica Pharmaceuticals Inc (STU:1NE) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

VRCA:USA 1NE:Germany

Address

44 West Gay Street, Suite 400, West Chester, PA, USA, 19380

Website

https://www.verrica.com

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts.

Verrica Pharmaceuticals Headlines

No Headlines